endogene.bio announced that the ERC project is going to rock.
Published
Signal category
Research & Knowledge
Quote
“That ERC project is going to rock”
— María Teresa Pérez Zaballos|endogene.bio team
Company
endogene.bio
Building a legacy in female health
- Industry
- Biotechnology Research
- Location
- Paris, France, FR
- Company size
- 13 employees
endogene.bio is building the biological data infrastructure for uterine health. 190 million women worldwide suffer from endometriosis, yet diagnosis still takes years and curative treatments remain unavailable. A fundamental challenge is the lack of high-quality human uterine biological data. By combining menstrual blood, advanced molecular profiling, and computational modeling, endogene.bio generates high-resolution biological data at scale, unlocking a previously inaccessible layer of human biology. Our work enables deeper understanding of disease mechanisms, patient stratification, biomarker discovery, and therapeutic development across uterine health. We collaborate with pharmaceutical companies, hospitals, clinics, and research organizations to accelerate the next generation of diagnostics and therapeutics in women's health.
Founded 2022